The Europe Dow Closes April Down 4.14% According To Dow Jones Indexes - Novo Nordisk Topped All 30 Europe Dow Components With 6.66% Gain For The Month

The Europe Dow, an equal-weighted index that measures 30 of the region’s leading blue-chip stocks, declined 4.14% in April, according to data compiled by Dow Jones Indexes, a leading global index provider.

The index’s top component performer for April was Novo Nordisk A/S Series B of Denmark, which closed up 6.66%. Shares of Diageo PLC (Great Britain) and GlaxoSmithKline PLC (Great Britain), up 4.91% and 3.71%, respectively, were the second- and third-leading stocks on The Europe Dow. UniCredit S.p.A. (Italy), which fell 20.46%, was The Europe Dow’s worst-performing stock in April.

By comparison, the Dow Jones Industrial Average ended April up 0.01%, The Asia Dow fell 1.09% and The Global Dow loss 2.93%. The Asia Dow is an equal-weighted, 30-stock index that measures leading blue-chips traded in the Asia/Pacific region; The Global Dow measures the performance of 150 leading companies from around the world.

For March 2012, The Europe Dow ended down 2.11%.

The Europe Dow, The Asia Dow and The Global Dow track leading blue-chip companies according to the same underlying principles as the Dow Jones Industrial Average. Stocks in The Europe Dow, The Asia Dow and The Global Dow are weighted equally; The Dow Jones Industrial Average uses a price-weighted methodology.

All index and component performance values are based on price returns/USD.

Below, please find a list of The Europe Dow’s 30 stocks and their April 2012 performances: